Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Horizon Therapeutics Public Ltd Co changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 609 | 7 | 618 | +16 |
| Shares | 203.8M | 204.8K | 205.9M | +2.34M (+1.1%) |
| Value | $22.0B | $22.1M | $21.8B | −$90.2M (−0.4%) |
7 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (86)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (70)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q4 2021 and filed for Q1 2022 without it.
Not filed for Q1 2022 yet (7)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Asymmetry Capital Management, L.P. | 137,610 | $14.8M |
| Andra AP-fonden | 58,000 | $6.25M |
| NEXT Financial Group, Inc | 7,243 | $781.0K |
| AlphaCentric Advisors LLC | 1,320 | $142.0K |
| Harbour Investments, Inc. | 510 | $55.0K |
| Bell Investment Advisors, Inc | 76 | $8.00K |
| Carroll Financial Associates, Inc. | 4 | $0 |